Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns ...
Hims & Hers Health Inc. shares surged as much as 18% and are on track to close at fresh record after Hunterbrook Media said the company is poised to be a major beneficiary of President-elect Donald ...
Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...
President-elect Donald Trump plans to nominate Marty Makary to lead the ... What To Know: Market optimism surrounding Makary's selection may have bolstered Hims & Hers shares on Monday as ...
(Bloomberg) -- Hims & Hers Health Inc. shares surged 24 ... beneficiary of President-elect Donald Trump’s nomination of Marty Makary to lead the Food and Drug Administration.
Hims & Hers Health Inc. shares surged as much ... major beneficiary of President-elect Donald Trump’s nomination of Marty Makary to lead the Food and Drug Administration. Hunterbrook said ...
Hunterbrook Capital said today it is long Hims & Hers Health. The company may soon have a key ally in the Trump administration in Dr. Marty Makary, an executive of a startup called Sesame ...
Mr. Trump nominated Marty Makary, MD, on Nov. 22 to head the FDA ... Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg ...